NASDAQ:TRIL
Delisted
Trillium Therapeutics Inc. Stock News
$18.44
+0 (+0%)
At Close: May 27, 2022
My Favorite Biotech Stock for 2021
10:00am, Monday, 04'th Jan 2021
This clinical-stage biotech stock could be a top buyout candidate in 2021.
5 Biotech Stocks That Generated 1,000%+ Returns In 2020
10:30am, Saturday, 26'th Dec 2020
The biopharma sector weathered the COVID-19 pandemic fairly well, with the Shares Nasdaq Biotechnology Etf (NASDAQ: IBB) outperforming the S&P 500 Index. This defensive sector also benefited from oppo
Implied Volatility Surging for Trillium (TRIL) Stock Options
09:47am, Thursday, 17'th Dec 2020
Investors need to pay close attention to Trillium (TRIL) stock based on the movements in the options market lately.
Could Trillium Fall Below $10 in 2021?
07:57pm, Wednesday, 16'th Dec 2020
A decline in the stock price plus positive clinical data equals opportunity.
These Were the 10 Best Healthcare Stocks of 2020
06:35am, Tuesday, 15'th Dec 2020
The highest performers of the year are biotechs fighting COVID-19 and cancer. Are they still buys for 2021?
How Did Trillium Stock Perform in 2020?
10:25am, Tuesday, 08'th Dec 2020
The micro-cap has shot up an incredible 1,400% this year.
Did You Miss Out on a 5000% Gain With Trillium Stock?
07:04am, Tuesday, 08'th Dec 2020
A new CEO and prioritization of research could have more big gains in store for the company
Trillium Therapeutics Presented Clinical Data at the 62nd ASH Annual Meeting and Provides Guidance for 2021
04:05pm, Monday, 07'th Dec 2020
CAMBRIDGE, Mass., Dec. 07, 2020 (GLOBE NEWSWIRE) -- Trillium Therapeutics Inc. ( “ Trillium ” or the “ Company ” ) (NASDAQ/TSX: TRIL), a clinical stage immuno-oncology company developing innov
These Were the 5 Best Cancer Stocks Of 2020
08:29am, Monday, 07'th Dec 2020
Biotech investors had more than just vaccines to think about this year.
This Biotech Is Up 1,500% This Year. Can It Make You Rich in 2021?
07:49am, Thursday, 26'th Nov 2020
Investors are catching on to the opportunity for this innovative cancer therapy, and so is big pharma.
Trillium Therapeutics to Present Clinical Data at the 62nd American Society of Hematology Annual Meeting
07:00am, Wednesday, 25'th Nov 2020
CAMBRIDGE, Mass., Nov. 25, 2020 (GLOBE NEWSWIRE) -- Trillium Therapeutics Inc. (NASDAQ/TSX: TRIL), a clinical stage immuno-oncology company developing innovative therapies for the treatment of cancer,
Trillium Therapeutics Reports Third Quarter 2020 Financial and Operating Results
07:00am, Monday, 16'th Nov 2020
CAMBRIDGE, Ma., Nov. 16, 2020 (GLOBE NEWSWIRE) -- Trillium Therapeutics Inc. (“Trillium” or the “Company”) (NASDAQ/TSX: TRIL), a clinical stage immuno-oncology company developing innovative th
Trillium Therapeutics: Investors To See Further Upside Via CD47 Focus
07:00am, Saturday, 14'th Nov 2020
Trillium Therapeutics has an encouraging pipeline with key differentiators that have attracted recent investor interest. The 2 major candidates, TTI-621 & 622 have shown monotherapy activity in a brea
Trillium Therapeutics Appoints Paolo Pucci to Its Board of Directors
04:05pm, Thursday, 12'th Nov 2020
Industry Veteran Brings Deep Executive and Commercial Experience to Trillium Board Industry Veteran Brings Deep Executive and Commercial Experience to Trillium Board
2 Cancer Stocks That Could Make You Filthy Rich
10:00am, Sunday, 08'th Nov 2020
Adaptimmune Therapeutics and Trillium Therapeutics could be big winners for early shareholders.
